🇺🇸 FDA
Pipeline program

Gastrodin Injection

2022072

Unknown small_molecule completed

Quick answer

Gastrodin Injection for Sensorineural Hearing Loss is a Unknown program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Sensorineural Hearing Loss
Phase
Unknown
Modality
small_molecule
Status
completed

Clinical trials